{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:13:59Z","timestamp":1793384039290,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.lanepe.2023.100738","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T16:57:41Z","timestamp":1698339461000},"page":"100738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe"],"prefix":"10.1016","volume":"34","author":[{"given":"Deniz","family":"G\u00f6kengin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teymur","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-4576","authenticated-orcid":false,"given":"Carlo","family":"Bienkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Liegon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-8715","authenticated-orcid":false,"given":"Ahmet \u00c7a\u011fkan","family":"\u0130nkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Stary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-8868","authenticated-orcid":false,"given":"Oriol","family":"Mitja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2023.100738_bib1","series-title":"HIV\/AIDS surveillance in Europe 2022: 2021 data","year":"2022"},{"key":"10.1016\/j.lanepe.2023.100738_bib3","series-title":"Continuum of HIV care - monitoring implementation of the Dublin Declaration on partnership to fight HIV\/AIDS in Europe and central Asia","year":"2021"},{"key":"10.1016\/j.lanepe.2023.100738_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/sextrans-2022-055455","article-title":"Sexual transmission of infections across Europe: appraising the present, scoping the future","author":"Geretti","year":"2022","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100738_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sextrans-2019-053972","article-title":"Substantial underdiagnosis of lymphogranuloma venereum in men who have sex with men in Europe: preliminary findings from a multicentre surveillance pilot","volume":"96","author":"Cole","year":"2020","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.lanepe.2023.100738_bib6","series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.lanepe.2023.100738_bib7","series-title":"HIV Combination prevention: monitoring implementation of the Dublin Declaration on partnership to fight HIV\/AIDS in Europe and Central Asia (2018 progress report)","year":"2020"},{"key":"10.1016\/j.lanepe.2023.100738_bib9","doi-asserted-by":"crossref","first-page":"j5011","DOI":"10.1136\/bmj.j5011","article-title":"Recent advances in pre-exposure prophylaxis for HIV","volume":"359","author":"Desai","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2023.100738_bib10","series-title":"Developing a national strategy for the prevention and control of sexually transmitted infections","year":"2019"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/vaccines11010122","article-title":"PrEP scale-up and PEP in central and eastern Europe: changes in time and the challenges we face with no expected HIV vaccine in the near future","volume":"11","author":"Gokengin","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lanepe.2023.100738_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijid.2018.03.007","article-title":"HIV care in Central and Eastern Europe: how close are we to the target?","volume":"70","author":"Gokengin","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"40","key":"10.1016\/j.lanepe.2023.100738_bib16","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.40.2200057","article-title":"Antimicrobial-resistant gonorrhoea: the national public health response, England, 2013 to 2020","volume":"27","author":"Merrick","year":"2022","journal-title":"Euro Surveill"},{"issue":"10370","key":"10.1016\/j.lanepe.2023.100738_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","article-title":"Monkeypox","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet"},{"issue":"10353","key":"10.1016\/j.lanepe.2023.100738_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study","volume":"400","author":"Tar\u00edn-Vicente","year":"2022","journal-title":"Lancet"},{"issue":"10380","key":"10.1016\/j.lanepe.2023.100738_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in people with advanced HIV infection: a global case series","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2023.100738_bib20","doi-asserted-by":"crossref","first-page":"100742","DOI":"10.1016\/j.lanepe.2023.100742","article-title":"Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe","volume":"34","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2023.100738_bib21","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.lanepe.2023.100737","article-title":"Treatment of bacterial sexually transmitted infections in Europe : gonorrhoea, Mycoplasma genitalium, and syphilis","volume":"34","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2023.100738_bib22","doi-asserted-by":"crossref","first-page":"100743","DOI":"10.1016\/j.lanepe.2023.100743","article-title":"Management of asymptomatic sexually transmitted infections in Europe: towards a differentiated, evidence-based approach","volume":"34","author":"Kenyon","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2023.100738_bib23","series-title":"Action plan for the health sector response to viral hepatitis in the WHO European Region","year":"2017"},{"key":"10.1016\/j.lanepe.2023.100738_bib24","series-title":"Action plan for the health sector response to HIV in the WHO European Region","year":"2017"},{"issue":"23","key":"10.1016\/j.lanepe.2023.100738_bib27","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100738_bib29","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/jac\/dkab263","article-title":"PrEP monitoring and HIV incidence after PrEP initiation in France: 2016-18 nationwide cohort study","volume":"76","author":"Tassi","year":"2021","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10013","key":"10.1016\/j.lanepe.2023.100738_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.lanepe.2023.100738_bib31","doi-asserted-by":"crossref","first-page":"30553","DOI":"10.2807\/1560-7917.ES.2017.22.25.30553","article-title":"Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)?","volume":"22","author":"Brown","year":"2017","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100738_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/QAD.0000000000002790","article-title":"Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM","volume":"35","author":"Estcourt","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.lanepe.2023.100738_bib34","series-title":"HIV in the UK: towards zero HIV transmissions by 2030","author":"Health England P","year":"2019"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100738_bib35","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/S2468-2667(22)00106-2","article-title":"Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study","volume":"7","author":"Jourdain","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.lanepe.2023.100738_bib36","series-title":"Bulletin de sant\u00e9 publique VIH\/sida","year":"2019"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100738_bib38","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2352-3018(22)00074-1","article-title":"Fate of people with HIV in jeopardy in Ukraine","volume":"9","author":"The Lancet H","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.lanepe.2023.100738_bib39","series-title":"National action plan on STIs, HIV and sexual health 2017\u20132022","year":"2018"},{"key":"10.1016\/j.lanepe.2023.100738_bib40","series-title":"Nationell strategi mot hiv\/aids och vissa andra smittsamma sjukdomar \u2013 prop.2005\/06:60","author":"Regeringskansliet","year":"2005"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/OLQ.0000000000001318","article-title":"Changes in the trend of sexually acquired Chlamydia infections in Sweden and the role of testing: a time series analysis","volume":"48","author":"Veli\u010dko","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100738_bib42","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3201\/eid1409.080153","article-title":"Emergence and spread of Chlamydia trachomatis variant, Sweden","volume":"14","author":"Herrmann","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100738_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/sextrans-2016-052992","article-title":"Ten years transmission of the new variant of Chlamydia trachomatis in Sweden: prevalence of infections and associated complications","volume":"94","author":"Dahlberg","year":"2018","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263550","article-title":"Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021)","volume":"17","author":"Taylor","year":"2022","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100738_bib46","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"Fonner","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.lanepe.2023.100738_bib47","series-title":"Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance. Technical brief","year":"2022"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100738_bib48","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2352-3018(22)00133-3","article-title":"Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study","volume":"9","author":"Molina","year":"2022","journal-title":"Lancet HIV"},{"issue":"21","key":"10.1016\/j.lanepe.2023.100738_bib49","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A\u00a0case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for disease control and prevention needlestick surveillance group","volume":"337","author":"Cardo","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2023.100738_bib50","first-page":"147","article-title":"Current perspectives in HIV post-exposure prophylaxis","volume":"6","author":"Sultan","year":"2014","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1016\/j.lanepe.2023.100738_bib51","first-page":"430","article-title":"Trends in HIV protection methods among HIV-negative men who have sex with men: results from the Rapport au sexe survey 2017-2019-2021, France","volume":"8","author":"Velter","year":"2022","journal-title":"Bull Epidemiol Hebd Sant\u00e9 Publique France"},{"issue":"41","key":"10.1016\/j.lanepe.2023.100738_bib52","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.41.1900598","article-title":"Estimating the 'PrEP Gap': how implementation and access to PrEP differ between countries in Europe and central asia in 2019","volume":"24","author":"Hayes","year":"2019","journal-title":"Euro Surveill"},{"issue":"10246","key":"10.1016\/j.lanepe.2023.100738_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","article-title":"Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial","volume":"396","author":"Mayer","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2023.100738_bib55","series-title":"US public health service: preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2021 update","author":"CDC","year":"2021"},{"issue":"10337","key":"10.1016\/j.lanepe.2023.100738_bib56","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","author":"Delany-Moretlwe","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100738_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100738_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/hiv.13451","article-title":"Long-acting injectable cabotegravir for PrEP: a game-changer in HIV prevention?","volume":"24","author":"Liegeon","year":"2022","journal-title":"HIV Med"},{"issue":"19","key":"10.1016\/j.lanepe.2023.100738_bib59","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","article-title":"Capsid inhibition with lenacapavir in multidrug-resistant HIV-1 infection","volume":"386","author":"Segal-Maurer","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100738_bib61","doi-asserted-by":"crossref","first-page":"e788","DOI":"10.1016\/S2352-3018(19)30238-3","article-title":"Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline","volume":"6","author":"Coelho","year":"2019","journal-title":"Lancet HIV"},{"issue":"22","key":"10.1016\/j.lanepe.2023.100738_bib62","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.lanepe.2023.100738_bib63","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100738_bib64","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/cid\/ciz866","article-title":"Doxycycline prophylaxis for bacterial sexually transmitted infections","volume":"70","author":"Grant","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100738_bib65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","article-title":"Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study","volume":"42","author":"Bolan","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100738_bib66","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.lanepe.2023.100738_bib67","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2023.100738_bib68","series-title":"ANRS 174 DOXYVAC: an open-label randomized trial to prevent STIs in MSM on PrEP. 30th CROI, conference on retroviruses and opportunistic infections","author":"Molina","year":"2023"},{"key":"10.1016\/j.lanepe.2023.100738_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00219-7","article-title":"Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study","author":"Tantalo","year":"2023","journal-title":"Lancet Microbe"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100738_bib70","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1128\/AAC.45.8.2198-2203.2001","article-title":"Growth and development of tetracycline-resistant Chlamydia suis","volume":"45","author":"Lenart","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib71","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jdv.17972","article-title":"2021 European guideline on the management of Mycoplasma genitalium infections","volume":"36","author":"Jensen","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.lanepe.2023.100738_bib73","series-title":"Position statement on doxycycline as prophylaxis for sexually transmitted infections 2021 update","author":"UKHSA","year":"2021"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral society\u2013USA Panel","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100738_bib75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1071\/SH23011","volume":"20","author":"Cornelisse","year":"2023","journal-title":"Sex Health"},{"key":"10.1016\/j.lanepe.2023.100738_bib76","author":"Health SF department of public"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100738_bib77","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/OLQ.0000000000001395","article-title":"Interest, concerns, and attitudes among men who have sex with men and health care providers toward prophylactic use of doxycycline against Chlamydia trachomatis infections and syphilis","volume":"48","author":"Park","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100738_bib78","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/OLQ.0000000000000942","article-title":"High interest in doxycycline for sexually transmitted infection postexposure prophylaxis in a multicity survey of men who have sex with men using a social networking application","volume":"46","author":"Spinelli","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100738_bib79","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/OLQ.0000000000001130","article-title":"High interest in syphilis pre-exposure and post-exposure prophylaxis among gay, bisexual and other men who have sex with men in vancouver and toronto","volume":"47","author":"Fusca","year":"2020","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100738_bib80","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S2352-3018(18)30210-8","article-title":"Doxycycline use in MSM taking PrEP","volume":"5","author":"Carveth-Johnson","year":"2018","journal-title":"Lancet HIV"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100738_bib81","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1016\/S2352-3018(19)30186-9","article-title":"Use of doxycycline prophylaxis among gay and bisexual men in Melbourne","volume":"6","author":"Chow","year":"2019","journal-title":"Lancet HIV"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100738_bib82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/sextrans-2022-055511","article-title":"Prophylactic use of antibiotics for sexually transmitted infections: awareness and use among HIV PrEP users in Belgium","volume":"98","author":"Vanbaelen","year":"2022","journal-title":"Sex Transm Infect"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100738_bib83","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/sextrans-2019-054325","article-title":"Use of doxycycline and other antibiotics to prevent STIs among men who have sex with men visiting sexual health clinics in the Netherlands","volume":"96","author":"Evers","year":"2020","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100738_bib84","first-page":"312","article-title":"Chemsex, sexual behaviour and STI-PrEP use among HIV-PrEP users during the COVID-19 pandemic in Brighton, UK","volume":"98","author":"Ringshall","year":"2022","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100738_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/sextrans-2020-054592","article-title":"Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK","volume":"97","author":"O'Halloran","year":"2021","journal-title":"Sex Transm Infect"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100738_bib86","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cmi.2016.08.022","article-title":"The challenges of preexposure prophylaxis for bacterial sexually transmitted infections","volume":"22","author":"Dubourg","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib87","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pec.2008.09.002","article-title":"Uma Tori! Evaluation of an STI\/HIV-prevention intervention for afro-caribbean women in the Netherlands","volume":"75","author":"Bertens","year":"2009","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.lanepe.2023.100738_bib88","series-title":"Doxycycline postexposure prophylaxis for prevention of STIs among cisgender women","author":"Stewart","year":"2023"},{"key":"10.1016\/j.lanepe.2023.100738_bib89","series-title":"Adherence to doxycycline PostExposure prophylaxis for STI prevention among cisgender women","first-page":"24","author":"Stewart","year":"2023"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/09564624211042444","article-title":"Countering the rise of syphilis: a role for doxycycline post-exposure prophylaxis?","volume":"33","author":"Tran","year":"2022","journal-title":"Int J STD AIDS"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100738_bib91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1473-3099(17)30726-0","article-title":"Doxycycline post-exposure prophylaxis: let the debate begin","volume":"18","author":"Fairley","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral society\u2013USA Panel","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib94","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/21645515.2020.1819742","article-title":"Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence","volume":"17","author":"Herzog","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"33","key":"10.1016\/j.lanepe.2023.100738_bib95","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.33.1700641","article-title":"Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017","volume":"23","author":"Ndumbi","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.lanepe.2023.100738_bib99","series-title":"Seventy-second regional committee for Europe: tel Aviv, 12\u201314 September 2022: regional action plans for ending AIDS and the epidemics of viral hepatitis and sexually transmitted infections 2022\u20132030","author":"Regional Committee for Europe, 72nd Session","year":"2022"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/vaccines10050793","article-title":"The global impact of hepatitis B vaccination on hepatocellular carcinoma","volume":"10","author":"Flores","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lanepe.2023.100738_bib101","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fonc.2020.00171","article-title":"Global trends in incidence rates of primary adult liver cancers: a systematic review and meta-analysis","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Front Oncol"},{"issue":"19","key":"10.1016\/j.lanepe.2023.100738_bib102","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMcp2108502","article-title":"Human papillomavirus vaccination","volume":"388","author":"Markowitz","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"9686","key":"10.1016\/j.lanepe.2023.100738_bib103","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib104","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.lanepe.2023.100738_bib105","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100738_bib106","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052016","article-title":"Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators","volume":"11","author":"Spayne","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100738_bib107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jnci\/djz074","article-title":"Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial","volume":"112","author":"Qiao","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100738_bib108","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A\u00a09-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"12 Suppl 2","key":"10.1016\/j.lanepe.2023.100738_bib109","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1093\/infdis\/jiaa668","article-title":"Hepatitis B vaccines","volume":"224","author":"Pattyn","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100738_bib110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/1060028020962050","article-title":"Heplisav-B: a hepatitis B vaccine with a novel adjuvant","volume":"55","author":"Champion","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100738_bib111","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28652","article-title":"Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine: a phase 3 randomized clinical trial","volume":"4","author":"Vesikari","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6241","key":"10.1016\/j.lanepe.2023.100738_bib112","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa8205","article-title":"VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100738_bib113","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1586\/14760584.2016.1161510","article-title":"Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis","volume":"15","author":"Yu","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100738_bib114","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","article-title":"Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?","volume":"20","author":"de la Maza","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100738_bib115","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection against Chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein","volume":"212","author":"Olsen","year":"2015","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100738_bib116","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/icb.2015.79","article-title":"A\u00a0multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-\u03b3\u207a CMI responses protects against a genital infection in minipigs","volume":"94","author":"B\u00f8je","year":"2016","journal-title":"Immunol Cell Biol"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100738_bib117","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib118","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.110.5.1206","article-title":"Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by -irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100738_bib119","doi-asserted-by":"crossref","first-page":"011533","DOI":"10.1128\/mBio.01153-18","article-title":"Long-term in\u00a0vitro culture of the syphilis spirochete Treponema pallidum subsp. pallidum","volume":"9","author":"Edmondson","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.lanepe.2023.100738_bib120","first-page":"1","article-title":"The Treponema pallidum outer membrane","volume":"415","author":"Radolf","year":"2018","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100738_bib121","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01006-18","article-title":"Sequence variation of rare outer membrane protein \u03b2-barrel domains in clinical strains provides insights into the evolution of Treponema pallidum subsp. pallidum, the syphilis spirochete","volume":"9","author":"Kumar","year":"2018","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100738_bib122","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00519-15","article-title":"Evidence for posttranslational protein flavinylation in the syphilis spirochete Treponema pallidum: structural and biochemical insights from the catalytic core of a periplasmic flavin-trafficking protein","volume":"6","author":"Deka","year":"2015","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib123","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1371\/journal.pntd.0002222","article-title":"Fine analysis of genetic diversity of the tpr gene family among treponemal species, subspecies and strains","volume":"7","author":"Centurion-Lara","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100738_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009753","article-title":"Longitudinal TprK profiling of in\u00a0vivo and in\u00a0vitro-propagated Treponema pallidum subsp. pallidum reveals accumulation of antigenic variants in absence of immune pressure","volume":"15","author":"Lin","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanepe.2023.100738_bib125","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3389\/fmicb.2019.01691","article-title":"Directly sequenced genomes of contemporary strains of syphilis reveal recombination-driven diversity in genes encoding predicted surface-exposed antigens","volume":"10","author":"Grillov\u00e1","year":"2019","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100738_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010063","article-title":"Treponema pallidum genome sequencing from six continents reveals variability in vaccine candidate genes and dominance of Nichols clade strains in Madagascar","volume":"15","author":"Lieberman","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanepe.2023.100738_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1126170","article-title":"Syphilis vaccine: challenges, controversies and opportunities","volume":"14","author":"\u00c1vila-Nieto","year":"2023","journal-title":"Front Immunol"},{"issue":"52","key":"10.1016\/j.lanepe.2023.100738_bib128","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1016\/j.vaccine.2022.11.002","article-title":"Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum","volume":"40","author":"Lukehart","year":"2022","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.lanepe.2023.100738_bib129","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1016\/j.vaccine.2022.11.002","article-title":"Immunization with a tri-antigen\u00a0syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum","volume":"40","author":"Lukehart","year":"2022","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100738_bib130","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00082-21","article-title":"Structural modeling of the Treponema pallidum outer membrane protein repertoire: a road map for deconvolution of syphilis pathogenesis and development of a syphilis vaccine","volume":"203","author":"Hawley","year":"2021","journal-title":"J\u00a0Bacteriol"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100738_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009612","article-title":"Genetic engineering of Treponema pallidum subsp. pallidum, the Syphilis Spirochete","volume":"17","author":"Romeis","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib132","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14760584.2016.1203262","article-title":"Vaccine development for syphilis","volume":"16","author":"Lithgow","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib133","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2023.100738_bib134","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.trsl.2020.03.004","article-title":"Vaccines to prevent genital herpes","volume":"220","author":"Egan","year":"2020","journal-title":"Transl Res"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100738_bib135","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/infdis\/jiy415","article-title":"Effects of different doses of GEN-003, a therapeutic vaccine for genital herpes simplex virus-2, on viral shedding and lesions: results of a randomized placebo-controlled trial","volume":"218","author":"Van Wagoner","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100738_bib138","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S1473-3099(22)00574-6","article-title":"Prevention of monkeypox with vaccines: a rapid review","volume":"22","author":"Poland","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanepe.2023.100738_bib139","article-title":"Mpox in people with past infection or a complete vaccination course: a global case series","author":"Hazra","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100738_bib140","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100738_bib141","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"10.1016\/j.lanepe.2023.100738_bib142","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.lanepe.2023.100738_bib143","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100738_bib144","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","article-title":"Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120-MF59 in adults","volume":"384","author":"Gray","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10102","key":"10.1016\/j.lanepe.2023.100738_bib146","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100738_bib147","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","article-title":"Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study","volume":"22","author":"Abara","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100738_bib148","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1473-3099(21)00754-4","article-title":"Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100738_bib149","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1093\/cid\/ciac436","article-title":"Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in southern California","volume":"76","author":"Bruxvoort","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100738_bib150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/OLQ.0000000000001771","article-title":"Meningococcus B vaccination effectiveness against Neisseria gonorrhoeae infection in people living with HIV: a case-control study","volume":"50","author":"Raccagni","year":"2023","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100738_bib151","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/infdis\/jiab581","article-title":"A\u00a0gonococcal vaccine has the potential to rapidly reduce the incidence of Neisseria gonorrhoeae infection among urban men who have sex with men","volume":"225","author":"Hui","year":"2022","journal-title":"J\u00a0Infect Dis"},{"issue":"36","key":"10.1016\/j.lanepe.2023.100738_bib152","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2015.07.015","article-title":"The potential impact of vaccination on the prevalence of gonorrhea","volume":"33","author":"Craig","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100738_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-022-14670-z","article-title":"The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study","volume":"23","author":"Looker","year":"2023","journal-title":"BMC Public Health"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776223001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776223001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:57:41Z","timestamp":1763009861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776223001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":132,"alternative-id":["S2666776223001576"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100738","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100760","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100742","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100766","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100737","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100743","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100738"}}